Free Webinar: Efficient Patient Identification in ALS Clinical Trials

In collaboration with Julius Clinical, TRICALS will present the webinar: “Efficient Patient…

Words Lucie van Leeuwen.Published November 3, 2020
Free Webinar: Efficient Patient Identification in ALS Clinical Trials

In collaboration with Julius Clinical, TRICALS will present the webinar:Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors”. The webinar will take place on November 10, 2020 at 18:00 CET.

We are pleased to announce that this webinar will be presented by: Prof. Dr. Leonard van den Berg (Professor of Neurology and Chair of TRICALS) and Dr. Ruben van Eijk (Assistant Professor and Medical Statistician) from our TRICALS Centre at UMC Utrecht, the Netherlands.

Topics that will be covered, include:

  • Prediction-based inclusion criteria
  • Defining the concept of fast vs slow progressors
  • Addressing disease heterogeneity and reduce variance
  • Regulatory perspective (EMA) on prediction-based patient selection

Don’t miss this opportunity and register now by clicking the link: https://bit.ly/3oAnz2L. The webinar will be recorded, so even if you can’t make it, make sure to sign up to receive the replay!


Share

Related news

The Lalji Family ALS Award
The Lalji Family ALS Award
The Lalji Family ALS Award is a global prize celebrating excellence in […]
More patients eligible for treatment research through innovative study design
More patients eligible for treatment research through innovative study design
Due to a new trial design for treatment research, more ALS patients […]
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its […]
Retrotope announces initiation of RT001 study in people with ALS
Retrotope announces initiation of RT001 study in people with ALS
Retrotope Inc has announced that the first participants have been enrolled in […]